Company performance
Add to research
Current Price
as of Feb 07, 2025$0.01
P/E Ratio
N/A
Market Cap
$933.06K
Description
Add to research
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerEVFM
- Price$0.00930.00%
Trading Information
- Market cap$0.93M
- Float100.00%
- Average Daily Volume (1m)406,753
- Average Daily Volume (3m)525,335
- EPS-$0.60
Company
- Revenue$17.10M
- Rev growth (1yr)-12.05%
- Net income-$2.36M
- Gross margin73.84%
- EBITDA margin-47.44%
- EBITDA-$2.13M
- EV$49.71M
- EV/Revenue2.91
- P/EN/A
- P/S0.05
- P/BN/A
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Factset Street Account